Shares of McKesson Co. (NYSE:MCK) have earned an average rating of “Hold” from the twenty analysts that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $177.50.
A number of research analysts recently issued reports on the stock. Royal Bank of Canada reiterated a “hold” rating and issued a $170.00 price objective on shares of McKesson in a report on Friday, October 27th. Robert W. Baird reiterated a “buy” rating and issued a $200.00 price objective on shares of McKesson in a report on Wednesday, January 17th. Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $164.00 price objective for the company in a report on Wednesday. Evercore ISI assumed coverage on shares of McKesson in a report on Thursday, January 4th. They issued an “outperform” rating and a $179.00 price objective for the company. Finally, Jefferies Group set a $165.00 price objective on shares of McKesson and gave the company a “hold” rating in a report on Wednesday, October 18th.
McKesson (MCK) traded up $2.81 on Wednesday, hitting $148.99. 1,050,201 shares of the stock were exchanged, compared to its average volume of 1,858,807. McKesson has a one year low of $133.82 and a one year high of $178.86. The company has a current ratio of 1.07, a quick ratio of 0.61 and a debt-to-equity ratio of 0.63. The firm has a market cap of $30,760.00, a P/E ratio of 7.17, a P/E/G ratio of 1.35 and a beta of 1.22.
The company also recently declared a quarterly dividend, which will be paid on Monday, April 2nd. Shareholders of record on Thursday, March 1st will be issued a dividend of $0.34 per share. The ex-dividend date is Wednesday, February 28th. This represents a $1.36 annualized dividend and a yield of 0.91%. McKesson’s payout ratio is 6.54%.
In other McKesson news, Chairman John H. Hammergren sold 65,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 14th. The shares were sold at an average price of $160.00, for a total transaction of $10,400,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.20% of the stock is currently owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the business. Icon Wealth Partners LLC acquired a new stake in shares of McKesson during the 4th quarter worth approximately $111,000. WFG Advisors LP grew its position in shares of McKesson by 5.0% during the 2nd quarter. WFG Advisors LP now owns 859 shares of the company’s stock worth $141,000 after buying an additional 41 shares during the period. Wealthcare Advisory Partners LLC acquired a new stake in shares of McKesson during the 3rd quarter worth approximately $155,000. Virtue Capital Management LLC acquired a new stake in shares of McKesson during the 4th quarter worth approximately $180,000. Finally, Focused Wealth Management Inc grew its position in shares of McKesson by 650.0% during the 4th quarter. Focused Wealth Management Inc now owns 1,200 shares of the company’s stock worth $187,000 after buying an additional 1,040 shares during the period. Hedge funds and other institutional investors own 86.63% of the company’s stock.
McKesson Company Profile
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.